Advertisement

Current Calcium Entry Blocker

  • Ronald D. Smith
  • Peter S. Wolf
  • John R. Regan
  • Stanley R. Jolly
Conference paper
Part of the Progress in Clinical Biochemistry and Medicine book series (PCBM, volume 6)

Abstract

The principle examples of the “first generation” of CEBs are verapamil, nifedipine and diltiazem. These three compounds are the reference standards against which new (and many older) compounds are compared. Each is a potent, and to varying degrees a selective CEB and, importantly, each has a distinct chemical structure. The differences in chemical structure give rise to differences in physical or chemical properties, distribution and metabolism, tissue binding characteristics and net biological effects. It is therefore not surprising that the therapeutic efficacy or tolerance of these agents may also be quite different (Sect. 4–5).

Keywords

Calcium Entry Myosin Light Chain Kinase Rabbit Aorta Vascular Contraction Antianginal Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • Ronald D. Smith
    • 1
  • Peter S. Wolf
    • 2
  • John R. Regan
    • 3
  • Stanley R. Jolly
    • 4
  1. 1.Department of Pharmaceutical ResearchDu Pont Critical CareWaukeganUSA
  2. 2.Sterling Drug, Inc.New YorkUSA
  3. 3.Rorer Central ResearchFort WashingtonUSA
  4. 4.East Carolina University, School of MedicineGreenvilleUSA

Personalised recommendations